Table 1. Changes in maximal muscle strength, serum myoglobin concentrations, creatin phosphokinase (CPK) activities, and VAS scores for muscle pain. There was no significantly difference between Placebo and LEAA ingestion. CI means confidence interval. Group P and Group A mean placebo group and LEAA group.
Mesurement item | Group | Pre | Post | Day 1 | Day 2 | Day 3 | Day 5 | Day 7 | |
---|---|---|---|---|---|---|---|---|---|
Muscle power (W) | Group P | Mean | 49.7 | 31.1 | 36.1 | 37 | 36.5 | 40.5 | 39.6 |
95%CI (Lower) | 41.9 | 23.4 | 28.3 | 29.3 | 28.7 | 32.7 | 31.8 | ||
95%CI (Upper) | 57.5 | 38.9 | 43.9 | 44.8 | 44.3 | 48.2 | 47.4 | ||
Group A | Mean | 48 | 30 | 37.2 | 37.2 | 35.9 | 41.4 | 43.7 | |
95%CI (Lower) | 40.2 | 22.2 | 29.4 | 29.4 | 28.1 | 33.6 | 35.9 | ||
95%CI (Upper) | 55.7 | 37.7 | 45 | 45 | 43.6 | 49.1 | 51.5 | ||
MB (ng/ml) | Group P | Mean | 33.2 | 36.1 | 59.4 | 440 | 615 | 200 | 67 |
95%CI (Lower) | 18.2 | 19.9 | 32.7 | 242 | 338 | 110 | 36.8 | ||
95%CI (Upper) | 60.3 | 65.7 | 108.2 | 801 | 1,120 | 363 | 122 | ||
Group A | Mean | 40.6 | 42 | 64.8 | 231 | 386 | 113 | 68 | |
95%CI (Lower) | 22.3 | 23.1 | 35.6 | 127 | 212 | 62.1 | 37.4 | ||
95%CI (Upper) | 73.8 | 76.4 | 117.9 | 420 | 703 | 205 | 124 | ||
CPK (IU/L) | Group P | Mean | 142 | 144 | 247 | 1,412 | 5,195 | 7,811 | 1,660 |
95%CI (Lower) | 65.8 | 66.8 | 115 | 657 | 2,416 | 3,633 | 772 | ||
95%CI (Upper) | 304 | 309 | 531 | 3,036 | 11,169 | 16,792 | 3,568 | ||
Group A | Mean | 187 | 187 | 286 | 810 | 3,006 | 2,380 | 1,112 | |
95%CI (Lower) | 86.9 | 87.2 | 133 | 377 | 1,398 | 1,107 | 517 | ||
95%CI (Upper) | 402 | 403 | 615 | 1,741 | 6,462 | 5,116 | 2,390 | ||
VAS scores for muscle pain | Group P | Mean | 0 | 3.1 | 5.3 | 6 | 5.3 | 2.4 | 1 |
95%CI (Lower) | −1.4 | 1.7 | 3.9 | 4.7 | 3.9 | 1.1 | −0.4 | ||
95%CI (Upper) | 1.3 | 4.4 | 6.6 | 7.4 | 6.6 | 3.7 | 2.3 | ||
Group A | Mean | 0.1 | 3 | 4.3 | 5.5 | 5.2 | 1.7 | 1 | |
95%CI (Lower) | −1.2 | 1.6 | 3 | 4.2 | 3.9 | 0.4 | −0.3 | ||
95%CI (Upper) | 1.5 | 4.3 | 5.7 | 6.8 | 6.6 | 3.1 | 2.4 |